Ignite Creation Date:
2025-12-24 @ 7:04 PM
Ignite Modification Date:
2026-02-09 @ 5:31 AM
Study NCT ID:
NCT06060457
Status:
COMPLETED
Last Update Posted:
2025-07-30
First Post:
2023-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
Sponsor:
ModernaTX, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-07
Completion Date Type:
ACTUAL
First Submit Date:
2023-09-23
First Submit QC Date:
None
Study First Post Date:
2023-09-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-06-05
Results First Submit QC Date:
None
Results First Post Date:
2025-07-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-10
Last Update Post Date:
2025-07-30
Last Update Post Date Type:
ACTUAL